Skip to content

Comparison of 22Mhz and 18Mhz High-frequency Probes for the Ultrasound Study of Temporal Arteries in Patients Suspected of Having Giant Cell Arteritis

Comparison of 2 Probes Frequencies in the Diagnosis of Giant Cell Arteritis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04204512
Acronym
ECHORTON
Enrollment
80
Registered
2019-12-19
Start date
2019-12-17
Completion date
2020-08-24
Last updated
2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Giant Cell Arteritis

Keywords

ultrasound,, giant cell arteritis

Brief summary

Evaluation of the structural features of temporal arteritis using two frequencies probes: 18 and 22Mhz.

Detailed description

Comparison of the results obtained by using 2 different frequencies probes in the diagnosis of giant cell arteritis

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* sedimentation rate\> 50 mm/h or recent unusual headache or unusual fever, recent visual trouble or jaw claudication, or induration temporal arteritis

Exclusion criteria

* previous diagnosis of giant cell arteritis and relapse of the giant cell arteritis and opposition to participate

Design outcomes

Primary

MeasureTime frameDescription
halo sign of temporal arteritisinclusionhypoechogenicity of the wall artery
compression sign of of temporal arteritisinclusionpersistent of increased inflammatory arteries wall

Secondary

MeasureTime frameDescription
halo sign of axillary arteritisinclusionhypoechogenicity of the wall artery
halo sign of carotid arteritisinclusionhypoechogenicity of the wall artery
other structural abnormalities in bilateral B modeinclusionstenosis, occlusion
other structural abnormalities in unilateral B modeinclusionstenosis, occlusion
halo sign of subclavian arteritisinclusionhypoechogenicity of the wall artery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026